Hoenemann, J.-N.
Moestl, S.
de Boni, L.
Hoffmann, F.
Arz, M.
Berger, L.
Pesta, D.
Heusser, K.
Mulder, E.
Lee, S. M. C.
Macias, B. R.
Tank, J.
Jordan, J.
Article History
Received: 7 February 2024
Revised: 19 March 2024
Accepted: 12 April 2024
First Online: 23 May 2024
Compliance with ethical standards
:
: JJ served as an advisor for Theravance, received research support from Boehringer Ingelheim and Novo Nordisk, served as a lecturer for Menarini Diagnostics and Berlin Chemie, and is co-founder of Eternygen GmbH. All others report no conflicts of interest.